Table 2.
Pharmacokinetic (PK) parameters of hepatitis B immunoglobulin in liver transplantation (LT) adults as a function of hepatitis virus replication status
| PK parameters | Period (days) | Nn | Rn | Rr |
|---|---|---|---|---|
| Clearance (mL/h) | 1–2 | 70 | 134 | 3260 |
| 3–7 | 46 | 64 | 450 | |
| 8–30 | 14 | 14 | 24 | |
| >30 | 7 | 7 | 13 | |
| Half-life (h) | 1–2 | 59 | 27 | 0.7 |
| 3–7 | 84 | 57 | 5 | |
| 8–30 | 266 | 270 | 123 | |
| >30 | 446 | 545 | 204 |
The Nn group in which patients were non-replicators at the time of lamivudine initiation and at the time of LT
The Rn group in which patients were replicators at the time of lamivudine initiation but non-replicators at the time of or within 2 weeks prior to LT
The Rr group in which patients were replicators at both occasions